Alcohol may elevate the expression of two enzymes called CYP2E1 and CYP2U1
Both drug response and brain physiology may be subsequently altered
2015-04-14
(Press-News.org) The prefrontal cortex (PFC) and amygdala (AMG) are brain regions that not only referee cognitive functions and emotional states, but also contribute to the reinforcing effects of alcohol and tobacco. Researchers already knew that alcohol and tobacco use can modulate cytochrome P450 expression in the liver and other tissues, but little is known about the effects of alcohol and tobacco on P450s in the human AMG. A new study focusing on two CYP2 enzymes that metabolize drugs and endogenous compounds has found that chronic drinking is associated with higher CYP2E1 and CYP2U1 protein expression in both brain regions, particularly the AMG.
Results will be published in the May 2015 online-only issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.
"The basolateral AMG, the specific amygdalar region analyzed in this study, seems to mediate the triggering of drug cravings by drug-related cues, such the sight of a lighter for a smoker, or the sight of a drink for an alcoholic," explained Francesca Toselli, a postdoctoral fellow in pharmacology and toxicology at the University of Toronto. "The PFC, on the other hand, mediates a relapse into drug use triggered by re-exposure to the drug itself, such as having a cigarette or a drink again after a period of abstinence."
P450 enzymes from the CYP2 family, Toselli added, are major contributors to the clearance of drugs that target the brain. Animal work has shown that this can occur directly in the brain and in living animals. Furthermore, nicotine appears to be able to alter the activity of some relevant CYP2 enzymes in the brain and other tissues.
Toselli and her colleagues examined 28 frozen human autopsy brain-tissue samples previously collected by qualified pathologists from 20 human subjects; the majority were male, only one sample was from a female subject - an alcoholic non-smoker. They analyzed and compared the expression of CYP2A6, CYP2B6, CYP2D6, CYP2E1, CYP2J2, CYP2S1, CYP2U1 and CYP2W1 proteins in PFC and AMG samples from alcoholic smokers, alcoholic non-smokers, non-alcoholic smokers, and non-alcoholic non-smokers in order to assess the effects of alcohol use and smoking on expression of these proteins.
"Our study shows that alcohol and cigarette smoke may increase the expression of two important drug- and endogenous compound-metabolizing enzymes in two brain areas that modulate drug addiction and affective behavior," said Toselli. She noted that this could lead to interactions between metabolism of drugs and endogenous substrates such as neurotransmitters which, in turn, could alter drug response and brain physiology.
"Both alcohol and cigarette smoke were associated with higher CYP2U1 expression in the PFC, and its expression was particularly elevated in subjects with a concurrent drinking and smoking history," she said. "Alcohol was also associated with higher CYP2U1 expression in the AMG. Furthermore, chronic drinking was associated with higher CYP2E1 expression in both brain regions analyzed, particularly in the AMG, and to a higher extent than what was observed for CYP2U1."
Toselli added that one of the major findings from her group's study is the potential effect of alcohol on the expression of CYP2U1 in the brain. "CYP2U1 is an enzyme that metabolizes, among other compounds, fatty acids and the tryptophan derivative, indole," she explained. "The major indole metabolite generated by CYP2U1 is oxindole, which is thought to contribute to the central nervous system depression associated with liver failure, such as hepatic encephalopathy. Our results could thus suggest a potential new research angle on the mechanisms underlying this disease."
INFORMATION:
Alcoholism: Clinical & Experimental Research (ACER) is the official journal of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. Co-authors of the ACER paper, "Expression of CYP2E1 and CYP2U1 Protein in Amygdala and Prefrontal Cortex: Influence of Alcoholism and Smoking," were: Iris M. Booth Depaz of the School of Biomedical Sciences; and Simon Worrall, Naomi Etheridge, Peter R. Dodd, Peter A. Wilce, Elizabeth M.J. Gillam of the School of Chemistry and Molecular Biosciences, all at The University of Queensland in St. Lucia, Brisbane, Australia. The study was funded by the National Health and Medical Research Council, and an International Postgraduate Research Award from the University of Queensland (Australia).
Contact: Francesca Toselli, Ph.D.
francesca.toselli@utoronto.ca
416.978.5155
University of Toronto
Alcoholism: Clinical & Experimental Research
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-14
This century's increase in addiction issues among U.S. youth may be related to their developmental need to fit in, particularly youth with social anxiety disorder (SAD), which could exacerbate the drink/trouble cycle. In addition, socially anxious youths may avoid participating in therapeutic activities during treatment for fear of negative peer appraisal. A study of the influence of SAD on clinical severity at intake, peer helping in Alcoholics Anonymous (AA) during treatment, and subsequent outcomes has found that almost half of the patients entering treatment had a persistent ...
2015-04-14
Cannabis is the most commonly used drug among adults who drink, besides tobacco, yet no study has directly compared those who use cannabis and alcohol simultaneously, or at the exact same time, versus those who use both separately and on a regular basis. A new study looks at the relationship between marijuana and alcohol use, finding that simultaneous users had double the odds of drunk driving, social consequences, and harms to self.
Results will be published in the May 2015 online-only issue of Alcoholism: Clinical & Experimental Research and are currently available ...
2015-04-14
WASHINGTON, DC - A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves and is damaged in MS, according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
"This study, for the first time, provides biological evidence of repair of damaged myelin in the human brain, and advances the field of neuro-reparative therapies," said study lead author Diego Cadavid, MD, with Biogen in Cambridge, Mass., ...
2015-04-14
Divorced women suffer heart attacks at higher rates than women who are continuously married, a new study from Duke Medicine has found. A woman who has been through two or more divorces is nearly twice as likely to have a heart attack when compared to their stably-married female peers, according to the findings.
Even among women who remarry after the stress of divorce, their heart attack risk remains elevated according to the study published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.
"Divorce is a major stressor, ...
2015-04-14
New York, NY -- It has been called a pioneering strategy for treating opioid addiction, and has already been adopted in a small yet growing number of jails and prisons in the United States. Now, a clinical trial published in the journal Addiction by researchers at NYU Langone Medical Center finds that the extended-release medication naltrexone (XR-NTX) is associated with a significant decline in relapse rates for a group of mostly heroin-dependent men after their release from New York City jails.
The NYU Langone researchers say that their study is the only randomized ...
2015-04-14
New York, April 14, 2015 - Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case of a deadly, rapidly spreading, infectious disease with no known cure, such as Ebola, ethical considerations demand that reliance only on RCTs be reexamined, according to a new Target Article now online and in print in the American Journal of Bioethics.
Authors Arthur Caplan, PhD and Carolyn Plunkett of the Division of ...
2015-04-14
Seeking a way to stimulate antitumor responses via the immune system, Steven Fiering, PhD, of Norris Cotton Cancer Center at Dartmouth, has identified the precise temperature that results in a distinct body-wide antitumor immune response that resists metastatic disease. Fiering's team published the research in the paper "Local Hyperthermia Treatment of Tumors Induces CD8+ T Cell-Mediated Resistance Against Distal and Secondary Tumors," which appeared in Nanomedicine: Nanotechnology, Biology and Medicine.
"Mild hyperthermia treatment of an identified tumor, prior to surgery ...
2015-04-14
NEW YORK, NY (April 14, 2015) -- The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a particularly aggressive form of non-Hodgkin's lymphoma, shows that many cases of the disease are driven by alterations in the JAK/STAT3 cell signaling pathway. The study also demonstrates, in mice implanted with human-derived ALCL tumors, that the disease can be inhibited by compounds that target this pathway, raising hopes that more effective treatments might soon be developed. The study, led by researchers at Columbia University ...
2015-04-14
Macrophages destroy bacteria by engulfing them in intracellular compartments, which they then acidify to kill or neutralize the bacteria. However, some pathogenic bacteria, such as Salmonella enterica, have evolved to exist and even grow while within these acidified compartments. Yet, how Salmonella responds to the acidic environment and how that environment affects the virulence of this pathogen are unclear. New research reveals that Salmonella fights acid with acid, by lowering the pH of its own interior in response to the acidification of the Salmonella-containing compartment ...
2015-04-14
An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper of Oxford University, UK, provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials that has taken place in the editorial pages of a number of medical journals in past months.
The researchers compared three different scenarios ...
LAST 30 PRESS RELEASES:
[Press-News.org] Alcohol may elevate the expression of two enzymes called CYP2E1 and CYP2U1
Both drug response and brain physiology may be subsequently altered
